Global Biological Safety Testing Market 2022 - Snapshot
This industry report offers market estimates of the global market, followed by a detailed analysis of the segmentation, technology, application, and region. The global market data on biological safety testing can be segmented by segmentation: analytical testing, in vitro testing, in vivo testing. The analytical testing segment captured the largest share of the market in 2021. Biological safety testing market is further segmented By technology animalbased, cellbased, in vitro kits, protein (mAb), others. The mAb segment held the largest share of the global biological safety testing market in 2021 and is anticipated to hold its share during the forecast period. Based on application, the biological safety testing market is segmented into: adventitious agents, host cell contaminant testing, product release testing, pyrogen and endotoxins testing, sterility and bioburden testing. In 2021, the product release testing segment made up the largest share of revenue generated by the biological safety testing market. On the basis of region, the biological safety testing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
The global biological safety testing market is highly competitive. The prominent players operating in the global biological safety testing market include BioReliance Corporation, Charles River Laboratories Inc., Eurofins ScientificSE, Lonza Group AG, SGS S.A., Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
- Get a detailed picture of the Global Biological Safety Testing Market
- Identify segments/areas to invest in over the forecast period in the Global Biological Safety Testing Market
- Understand the competitive environment, the markets leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Part 2. Introduction
Part 3. Biological safety testing market overview
Part 4. Market breakdown by segmentation
In vitro testing
In vivo testing
Part 5. Market breakdown by technology
In vitro kits
Part 6. Market breakdown by application
Host cell contaminant testing
Product release testing
Pyrogen and endotoxins testing
Sterility and bioburden testing
Part 7. Market breakdown by region
Rest of the World (RoW)
Part 8. Key companies
Charles River Laboratories, Inc.
Lonza Group AG
Thermo Fisher Scientific, Inc.
WuXi AppTec Co., Ltd.
Part 9. Methodology
This new report from provides analysis of the endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts, market shares and strategic profiles of leading suppliers.The report isView Report
2022 Global Coagulation Market AnalysisLeading and Emerging Supplier Sales, Shares and Instrument Installed Base by Geographic Region This new report from provides granular data and analysis not available fromView Report
The global biological therapies for cancer market is expected to increase by USD 50 billion, at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2028, according toView Report
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Biological Imaging Reagents Report by Material, Application, andView Report
Fill The Form For Sample Request